This study is currently not recruiting participants.

Programmed Human Hematopoietic Stem Cells for Systemic Treatment of AMD

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

The purpose of this study is to obtain hematopoietic stem cells (blood stem cells) from a subject?s blood. Once the cells are isolated, the cells will be tested to see if they can correct the dysfunction in the retina of a mouse model of age related macular degeneration. The response of subject?s cells will be compared to those of individuals with different degrees of severity of AMD and to healthy individuals. The animal model has the ability to accept human cells without rejecting the cells.

Description

The purpose of this study is to obtain hematopoietic stem cells (blood stem cells) from a subject?s blood. Once the cells are isolated, the cells will be tested to see if they can correct the dysfunction in the retina of a mouse model of age related macular degeneration. The response of subject?s cells will be compared to those of individuals with different degrees of severity of AMD and to healthy individuals. The animal model has the ability to accept human cells without rejecting the cells.

Details
Condition Macular Degeneration
Age 100years or below
Clinical Study IdentifierTX3593
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.